Danaher Corporation has entered into a definitive agreement with General Electric (GE) Company to acquire a very lucrative Biopharma business unit of GE Life Sciences. Biopharma unit of GE Life Sciences, is the leading provider of instruments, consumables, and software that support the research, discovery, process development and manufacturing workflows of biopharmaceutical drugs. The business comprises process chromatography hardware and consumables, cell culture media, single-use technologies, development instrumentation and consumables, and service.
Danaher to Solidify its Leadership in Bioprocessing - Post the Acquisition of the Biopharma Business of General Electric Life Sciences
Posted by
MarketsandMarkets on Apr 15, 2019 9:54:19 PM
0 Comments Click here to read/write comments
Topics: healthcare, Bioprocessing